Peter, for the first time since the beginning of civilisation - the biotech index is following the broad markets. Now why is that? Could it be accounting problems? Personally I wouldn't touch this sector until we see two things; one, capitulation ... two, J&J buying up the juniors ten at a time. I'm thinking consolidation in this sector is the inevitable bottom.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.